Last reviewed · How we verify
FERROUS SULFATE
At a glance
| Generic name | FERROUS SULFATE |
|---|---|
| Sponsor | Pfizer |
| Drug class | ferrous sulfate |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
| First approval | 1946 |
Approved indications
- Anemia of prematurity
- Iron deficiency anemia
- Megaloblastic anemia due to folate deficiency
- Mineral Deficiency Prevention
- Mineral deficiency
- Vitamin Deficiency Prevention
- Vitamin deficiency
Common side effects
Drug interactions
- dolutegravir
- dolutegravir
- enoxacin
- enoxacin
- gatifloxacin
- levodopa
- levodopa
- levofloxacin
- levofloxacin
- levothyroxine sodium
- levothyroxine sodium
- lomefloxacin
Key clinical trials
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial (PHASE2)
- Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity (NA)
- Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.
- Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study (PHASE3)
- EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA (NA)
- Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy (NA)
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FERROUS SULFATE CI brief — competitive landscape report
- FERROUS SULFATE updates RSS · CI watch RSS
- Pfizer portfolio CI